DEA Announces Important Change to Registration Requirement (January 12, 2023)

Letter from Anne Milgram, Administrator

See original signed document

Requirements for training for Medication Assisted Treatment as part of the MATE Act (PDF) (March 27, 2023)

Please see the letter which outlines the requirements for training for Medication Assisted Treatment as part of the MATE Act, which was part of the Omnibus Bill at the end of December 2022. DEA was given 90 days to let practitioners know how to meet the MATE Act’s training requirement which is tied to their initial or renewal DEA registration beginning on June 27, 2023. This letter provides the information to the practitioners as to how they can meet those training requirements.

IQVIA Report on Stimulant Trends from 2012 - 2021 (PDF) (October 31, 2022)

Guidance / Questions and Answers

• Updated DEA Registration Certificate after Removal of X-Waiver
  
• Buprenorphine (MOUD) Q&A
• Registration Q&A
  

Please visit SAMSHA for additional information:

https://www.samhsa.gov/medications-substance-use-disorders/provider-support-services/recommendations-curricular-elements-substance-use-disorders-training

https://www.samhsa.gov/medication-assisted-treatment/removal-data-waiver-requirement

https://www.samhsa.gov/medication-assisted-treatment

For information regarding DEA’s Diversion Control Division, contact the Diversion Control Division Policy Section at ODLP@dea.gov if you seek additional assistance regarding this or any other matter.